

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cerebellar granule cell differentiation (GO:0021707) | 9.58628640 |
| 2 | response to pheromone (GO:0019236) | 8.64947838 |
| 3 | pyrimidine nucleobase catabolic process (GO:0006208) | 7.60041158 |
| 4 | cerebellar Purkinje cell differentiation (GO:0021702) | 7.04323587 |
| 5 | cell differentiation in hindbrain (GO:0021533) | 6.72462475 |
| 6 | neuronal action potential propagation (GO:0019227) | 6.65692257 |
| 7 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 6.45604852 |
| 8 | locomotory exploration behavior (GO:0035641) | 6.27027827 |
| 9 | gamma-aminobutyric acid transport (GO:0015812) | 6.11277634 |
| 10 | behavioral response to nicotine (GO:0035095) | 5.93440111 |
| 11 | nucleobase catabolic process (GO:0046113) | 5.90967244 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 5.90230908 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.86255632 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 5.79360757 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.66309329 |
| 16 | sodium ion export (GO:0071436) | 5.44784370 |
| 17 | short-term memory (GO:0007614) | 5.39909932 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31912889 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 5.30417765 |
| 20 | neurofilament cytoskeleton organization (GO:0060052) | 5.22720565 |
| 21 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 5.21645509 |
| 22 | axonal fasciculation (GO:0007413) | 5.19267930 |
| 23 | synaptic vesicle maturation (GO:0016188) | 5.09402615 |
| 24 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.99973614 |
| 25 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.94260856 |
| 26 | C4-dicarboxylate transport (GO:0015740) | 4.93871854 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.87606484 |
| 28 | positive regulation of mitochondrial fission (GO:0090141) | 4.64906409 |
| 29 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.62077479 |
| 30 | establishment of mitochondrion localization (GO:0051654) | 4.59449183 |
| 31 | synaptic vesicle exocytosis (GO:0016079) | 4.56725515 |
| 32 | protein localization to synapse (GO:0035418) | 4.54586891 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.54093256 |
| 34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.49694132 |
| 35 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.49021805 |
| 36 | neuromuscular process controlling posture (GO:0050884) | 4.48366058 |
| 37 | regulation of collateral sprouting (GO:0048670) | 4.48316764 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 4.47972561 |
| 39 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.42499746 |
| 40 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.41078604 |
| 41 | vocalization behavior (GO:0071625) | 4.36946078 |
| 42 | retinal ganglion cell axon guidance (GO:0031290) | 4.30339830 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.25814912 |
| 44 | neuron recognition (GO:0008038) | 4.24870151 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.23357173 |
| 46 | long-term memory (GO:0007616) | 4.22782469 |
| 47 | mitochondrion transport along microtubule (GO:0047497) | 4.22419103 |
| 48 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.22419103 |
| 49 | potassium ion import (GO:0010107) | 4.17296113 |
| 50 | glutamate secretion (GO:0014047) | 4.08751297 |
| 51 | musculoskeletal movement (GO:0050881) | 4.04939605 |
| 52 | multicellular organismal movement (GO:0050879) | 4.04939605 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 4.00373976 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.99205230 |
| 55 | adult walking behavior (GO:0007628) | 3.91903830 |
| 56 | neurotransmitter transport (GO:0006836) | 3.91201122 |
| 57 | negative regulation of axon guidance (GO:1902668) | 3.89266547 |
| 58 | exploration behavior (GO:0035640) | 3.87405931 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.85472908 |
| 60 | retinal cone cell development (GO:0046549) | 3.84903758 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84529796 |
| 62 | olfactory bulb development (GO:0021772) | 3.82546436 |
| 63 | potassium ion homeostasis (GO:0055075) | 3.82166327 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.80720879 |
| 65 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.80642314 |
| 66 | membrane depolarization during action potential (GO:0086010) | 3.78111496 |
| 67 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.77767025 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.70889965 |
| 69 | proline transport (GO:0015824) | 3.69888079 |
| 70 | neuromuscular process controlling balance (GO:0050885) | 3.68269927 |
| 71 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.67934824 |
| 72 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.67934824 |
| 73 | neuron cell-cell adhesion (GO:0007158) | 3.67728805 |
| 74 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.67594652 |
| 75 | regulation of neurotransmitter levels (GO:0001505) | 3.67518586 |
| 76 | negative regulation of dendrite development (GO:2000171) | 3.67421596 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.61889079 |
| 78 | layer formation in cerebral cortex (GO:0021819) | 3.61886771 |
| 79 | regulation of beta-amyloid formation (GO:1902003) | 3.61123642 |
| 80 | central nervous system neuron axonogenesis (GO:0021955) | 3.61001830 |
| 81 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.58626558 |
| 82 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.58626558 |
| 83 | cellular sodium ion homeostasis (GO:0006883) | 3.57453738 |
| 84 | negative regulation of hormone metabolic process (GO:0032351) | 3.52600837 |
| 85 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.52600837 |
| 86 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.52414157 |
| 87 | glycine transport (GO:0015816) | 3.50767014 |
| 88 | positive regulation of heat generation (GO:0031652) | 3.49934697 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 3.42803224 |
| 90 | acidic amino acid transport (GO:0015800) | 3.41740387 |
| 91 | neuronal ion channel clustering (GO:0045161) | 3.41144370 |
| 92 | mechanosensory behavior (GO:0007638) | 3.40683877 |
| 93 | regulation of postsynaptic membrane potential (GO:0060078) | 3.40601212 |
| 94 | protein polyglutamylation (GO:0018095) | 3.40090577 |
| 95 | negative regulation of catecholamine secretion (GO:0033604) | 3.39477047 |
| 96 | prepulse inhibition (GO:0060134) | 3.38651890 |
| 97 | membrane depolarization (GO:0051899) | 3.38308999 |
| 98 | presynaptic membrane organization (GO:0097090) | 3.38220735 |
| 99 | response to auditory stimulus (GO:0010996) | 3.36465509 |
| 100 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.36202069 |
| 101 | auditory behavior (GO:0031223) | 3.35245238 |
| 102 | regulation of neurotransmitter secretion (GO:0046928) | 3.34874110 |
| 103 | positive regulation of synapse assembly (GO:0051965) | 3.34769585 |
| 104 | L-glutamate transport (GO:0015813) | 3.31474176 |
| 105 | presynaptic membrane assembly (GO:0097105) | 3.30678734 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 3.30445046 |
| 107 | dendrite morphogenesis (GO:0048813) | 3.30371437 |
| 108 | establishment of nucleus localization (GO:0040023) | 3.29879430 |
| 109 | regulation of heat generation (GO:0031650) | 3.29818589 |
| 110 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.26039855 |
| 111 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.25503674 |
| 112 | negative regulation of axonogenesis (GO:0050771) | 3.24808402 |
| 113 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.21936333 |
| 114 | dendrite development (GO:0016358) | 3.21260600 |
| 115 | synaptic transmission, cholinergic (GO:0007271) | 3.20895511 |
| 116 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20744034 |
| 117 | postsynaptic membrane organization (GO:0001941) | 3.19129759 |
| 118 | peristalsis (GO:0030432) | 3.16696445 |
| 119 | positive regulation of membrane potential (GO:0045838) | 3.16481392 |
| 120 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.16233774 |
| 121 | regulation of glucocorticoid secretion (GO:2000849) | 3.16171286 |
| 122 | regulation of mitochondrial fission (GO:0090140) | 3.15330535 |
| 123 | regulation of cell communication by electrical coupling (GO:0010649) | 3.15267618 |
| 124 | spinal cord development (GO:0021510) | 3.13292084 |
| 125 | response to histamine (GO:0034776) | 3.13014343 |
| 126 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 3.12903023 |
| 127 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.12077994 |
| 128 | relaxation of cardiac muscle (GO:0055119) | 3.11775452 |
| 129 | synapse assembly (GO:0007416) | 3.11619623 |
| 130 | regulation of fever generation (GO:0031620) | 3.11502020 |
| 131 | positive regulation of potassium ion transport (GO:0043268) | 3.10614177 |
| 132 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.10472488 |
| 133 | cerebellar Purkinje cell layer development (GO:0021680) | 3.09976492 |
| 134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.09521186 |
| 135 | neuromuscular synaptic transmission (GO:0007274) | 3.08258488 |
| 136 | membrane hyperpolarization (GO:0060081) | 3.07798494 |
| 137 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.07227494 |
| 138 | regulation of vesicle fusion (GO:0031338) | 3.06615791 |
| 139 | membrane repolarization (GO:0086009) | 3.04449531 |
| 140 | detection of calcium ion (GO:0005513) | 3.03723588 |
| 141 | hippocampus development (GO:0021766) | 3.03624707 |
| 142 | regulation of neurotransmitter transport (GO:0051588) | 3.03368817 |
| 143 | positive regulation of amino acid transport (GO:0051957) | 3.02683015 |
| 144 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.02009482 |
| 145 | axon extension involved in axon guidance (GO:0048846) | 3.02009482 |
| 146 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.01291763 |
| 147 | protein localization to cilium (GO:0061512) | 3.01002644 |
| 148 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.99684177 |
| 149 | synapse organization (GO:0050808) | 2.98629043 |
| 150 | dendritic spine organization (GO:0097061) | 2.97281266 |
| 151 | negative regulation of axon extension (GO:0030517) | 2.96888794 |
| 152 | long term synaptic depression (GO:0060292) | 2.96263362 |
| 153 | neuromuscular process (GO:0050905) | 2.96228270 |
| 154 | chemosensory behavior (GO:0007635) | 2.95769683 |
| 155 | gonadal mesoderm development (GO:0007506) | 2.95521750 |
| 156 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.93778834 |
| 157 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.93596360 |
| 158 | mating behavior (GO:0007617) | 2.92767615 |
| 159 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.91516362 |
| 160 | regulation of dopamine secretion (GO:0014059) | 2.91177197 |
| 161 | epithelial cilium movement (GO:0003351) | 2.90971078 |
| 162 | negative regulation of amine transport (GO:0051953) | 2.90963772 |
| 163 | synaptic transmission (GO:0007268) | 2.90926997 |
| 164 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.90564895 |
| 165 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.90509133 |
| 166 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88561220 |
| 167 | regulation of Rac GTPase activity (GO:0032314) | 2.84386749 |
| 168 | axon extension (GO:0048675) | 2.84178763 |
| 169 | regulation of extent of cell growth (GO:0061387) | 2.82884262 |
| 170 | negative regulation of heart rate (GO:0010459) | 2.82495051 |
| 171 | neuron migration (GO:0001764) | 2.79530698 |
| 172 | axonogenesis (GO:0007409) | 2.78423734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.09503088 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.62799352 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.60302267 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.52451502 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.19260395 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07036993 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 3.00940988 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 3.00940988 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95720509 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84469761 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.75275373 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.74773467 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.70309988 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62573704 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61831475 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60149984 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.58164561 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54331955 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53173055 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52467434 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.51813399 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28307649 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27963083 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23162403 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17450969 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12560716 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07951649 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01643418 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97057890 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.92609806 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90371215 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.75846992 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70479489 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.62237274 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61217261 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59535171 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56279265 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52630499 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52385415 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51087234 |
| 41 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46082508 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37386670 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37201620 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36748552 |
| 45 | AR_19668381_ChIP-Seq_PC3_Human | 1.36632798 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35169141 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.34544667 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31618256 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31613369 |
| 50 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.26971092 |
| 51 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26636939 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22683374 |
| 53 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.19862151 |
| 54 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19815745 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19232129 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18872671 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18205192 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17932943 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17894167 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17722749 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17329329 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17272325 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15682361 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15594784 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15270521 |
| 66 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15243019 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14114195 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13662559 |
| 69 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.12843069 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12642161 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12578318 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11969793 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11946151 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10802258 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10420584 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09322557 |
| 77 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09124224 |
| 78 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08572403 |
| 79 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08321056 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07068645 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07014531 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05989135 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05159770 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05098360 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05028522 |
| 86 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05022098 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04751258 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04607971 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04456892 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03863782 |
| 91 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02401082 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 1.01248149 |
| 93 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.99786368 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.99388604 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99185654 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99065385 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98852402 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98412666 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.97195578 |
| 100 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97005240 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96645264 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96340452 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96340452 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95913635 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95579442 |
| 106 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95477405 |
| 107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95425339 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95147524 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95016182 |
| 110 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94417822 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94305299 |
| 112 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93706618 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93340637 |
| 114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93058548 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91115114 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89834186 |
| 117 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89290471 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88860828 |
| 119 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88594356 |
| 120 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88279017 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87009379 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85676842 |
| 123 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.84942621 |
| 124 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.84076825 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83928070 |
| 126 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83689901 |
| 127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83565139 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83286677 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83121941 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82399588 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82101285 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81217042 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81126588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009046_muscle_twitch | 5.61202245 |
| 2 | MP0002822_catalepsy | 4.94445185 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.83235090 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.94447540 |
| 5 | MP0008569_lethality_at_weaning | 3.90117072 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.50843738 |
| 7 | MP0002272_abnormal_nervous_system | 3.39429918 |
| 8 | MP0002064_seizures | 3.11725890 |
| 9 | MP0009745_abnormal_behavioral_response | 3.10082265 |
| 10 | MP0001440_abnormal_grooming_behavior | 2.85316500 |
| 11 | MP0002067_abnormal_sensory_capabilities | 2.83210757 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.78645773 |
| 13 | MP0001529_abnormal_vocalization | 2.63833385 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.63662287 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.63422837 |
| 16 | MP0004147_increased_porphyrin_level | 2.53884284 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.53743051 |
| 18 | MP0004270_analgesia | 2.53491052 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.51507112 |
| 20 | MP0002184_abnormal_innervation | 2.50488725 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.47034585 |
| 22 | MP0003880_abnormal_central_pattern | 2.41413128 |
| 23 | MP0004142_abnormal_muscle_tone | 2.29848064 |
| 24 | MP0002736_abnormal_nociception_after | 2.27323343 |
| 25 | MP0001501_abnormal_sleep_pattern | 2.23163360 |
| 26 | MP0001486_abnormal_startle_reflex | 2.19181576 |
| 27 | MP0002735_abnormal_chemical_nociception | 2.12270942 |
| 28 | MP0004742_abnormal_vestibular_system | 2.11398687 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.93789667 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.90858036 |
| 31 | MP0004924_abnormal_behavior | 1.90807968 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.90807968 |
| 33 | MP0005645_abnormal_hypothalamus_physiol | 1.81215519 |
| 34 | MP0004885_abnormal_endolymph | 1.79906831 |
| 35 | MP0001970_abnormal_pain_threshold | 1.75561972 |
| 36 | MP0001502_abnormal_circadian_rhythm | 1.68813493 |
| 37 | MP0003632_abnormal_nervous_system | 1.67658608 |
| 38 | MP0002066_abnormal_motor_capabilities/c | 1.63487601 |
| 39 | MP0001984_abnormal_olfaction | 1.63285549 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.54854825 |
| 41 | MP0000955_abnormal_spinal_cord | 1.53183176 |
| 42 | MP0002254_reproductive_system_inflammat | 1.52941580 |
| 43 | MP0008877_abnormal_DNA_methylation | 1.48282935 |
| 44 | MP0003329_amyloid_beta_deposits | 1.45095821 |
| 45 | MP0003137_abnormal_impulse_conducting | 1.40751638 |
| 46 | MP0003122_maternal_imprinting | 1.37149210 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.35228171 |
| 48 | MP0003011_delayed_dark_adaptation | 1.33793644 |
| 49 | MP0003631_nervous_system_phenotype | 1.32770528 |
| 50 | MP0000778_abnormal_nervous_system | 1.31620015 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.31611051 |
| 52 | MP0003633_abnormal_nervous_system | 1.31031717 |
| 53 | MP0005171_absent_coat_pigmentation | 1.29332153 |
| 54 | MP0000920_abnormal_myelination | 1.28037261 |
| 55 | MP0003690_abnormal_glial_cell | 1.26900631 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.25786659 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.25424682 |
| 58 | MP0004043_abnormal_pH_regulation | 1.21279887 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.20343679 |
| 60 | MP0004811_abnormal_neuron_physiology | 1.20013805 |
| 61 | MP0003879_abnormal_hair_cell | 1.18971439 |
| 62 | MP0002152_abnormal_brain_morphology | 1.16131993 |
| 63 | MP0001188_hyperpigmentation | 1.15864502 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.15321883 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.14278325 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.13154432 |
| 67 | MP0002751_abnormal_autonomic_nervous | 1.11730412 |
| 68 | MP0002229_neurodegeneration | 1.11553515 |
| 69 | MP0003861_abnormal_nervous_system | 1.10808156 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.06880756 |
| 71 | MP0003787_abnormal_imprinting | 1.06039434 |
| 72 | MP0006292_abnormal_olfactory_placode | 1.05034643 |
| 73 | MP0006276_abnormal_autonomic_nervous | 1.03514639 |
| 74 | MP0004510_myositis | 1.03184530 |
| 75 | MP0001905_abnormal_dopamine_level | 1.00732398 |
| 76 | MP0004036_abnormal_muscle_relaxation | 0.98219125 |
| 77 | MP0008872_abnormal_physiological_respon | 0.97407750 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.95424684 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.90735316 |
| 80 | MP0000751_myopathy | 0.89234268 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.88620994 |
| 82 | MP0005083_abnormal_biliary_tract | 0.88394276 |
| 83 | MP0004085_abnormal_heartbeat | 0.88331081 |
| 84 | MP0004484_altered_response_of | 0.87896535 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.87046049 |
| 86 | MP0004084_abnormal_cardiac_muscle | 0.84603076 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.82869320 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.82250010 |
| 89 | MP0008874_decreased_physiological_sensi | 0.82043189 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80334285 |
| 91 | MP0005195_abnormal_posterior_eye | 0.79942630 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.78079545 |
| 93 | MP0004858_abnormal_nervous_system | 0.77610096 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.76082369 |
| 95 | MP0003634_abnormal_glial_cell | 0.76026647 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.74508448 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72822332 |
| 98 | MP0003718_maternal_effect | 0.69403594 |
| 99 | MP0004233_abnormal_muscle_weight | 0.68975075 |
| 100 | MP0010769_abnormal_survival | 0.68107573 |
| 101 | MP0004133_heterotaxia | 0.66760798 |
| 102 | MP0003123_paternal_imprinting | 0.65801630 |
| 103 | MP0010768_mortality/aging | 0.65429982 |
| 104 | MP0010770_preweaning_lethality | 0.64024638 |
| 105 | MP0002082_postnatal_lethality | 0.64024638 |
| 106 | MP0005391_vision/eye_phenotype | 0.63827636 |
| 107 | MP0005084_abnormal_gallbladder_morpholo | 0.63809465 |
| 108 | MP0003121_genomic_imprinting | 0.62561100 |
| 109 | MP0002938_white_spotting | 0.62233560 |
| 110 | MP0002081_perinatal_lethality | 0.60803214 |
| 111 | MP0003283_abnormal_digestive_organ | 0.60261841 |
| 112 | MP0005499_abnormal_olfactory_system | 0.59834622 |
| 113 | MP0005394_taste/olfaction_phenotype | 0.59834622 |
| 114 | MP0000747_muscle_weakness | 0.59757974 |
| 115 | MP0000604_amyloidosis | 0.58737052 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.58562023 |
| 117 | MP0005646_abnormal_pituitary_gland | 0.58380001 |
| 118 | MP0005187_abnormal_penis_morphology | 0.58203664 |
| 119 | MP0005253_abnormal_eye_physiology | 0.57763558 |
| 120 | MP0005535_abnormal_body_temperature | 0.56441720 |
| 121 | MP0008995_early_reproductive_senescence | 0.56279965 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.56090163 |
| 123 | MP0003698_abnormal_male_reproductive | 0.55107752 |
| 124 | MP0003646_muscle_fatigue | 0.54285842 |
| 125 | MP0008770_decreased_survivor_rate | 0.53624081 |
| 126 | MP0003567_abnormal_fetal_cardiomyocyte | 0.52880758 |
| 127 | MP0001177_atelectasis | 0.52832366 |
| 128 | MP0001943_abnormal_respiration | 0.52691834 |
| 129 | MP0003956_abnormal_body_size | 0.52029607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive cerebellar ataxia (HP:0002073) | 7.89457091 |
| 2 | Action tremor (HP:0002345) | 7.60375071 |
| 3 | Gaze-evoked nystagmus (HP:0000640) | 6.07200879 |
| 4 | Focal motor seizures (HP:0011153) | 6.01807691 |
| 5 | Scanning speech (HP:0002168) | 5.82297194 |
| 6 | Visual hallucinations (HP:0002367) | 5.79969333 |
| 7 | Atonic seizures (HP:0010819) | 5.66753720 |
| 8 | Myokymia (HP:0002411) | 5.51650480 |
| 9 | Dysdiadochokinesis (HP:0002075) | 5.39849456 |
| 10 | Febrile seizures (HP:0002373) | 5.37353750 |
| 11 | Focal seizures (HP:0007359) | 5.08098709 |
| 12 | Dysmetric saccades (HP:0000641) | 4.98860512 |
| 13 | Impaired smooth pursuit (HP:0007772) | 4.88386314 |
| 14 | Intention tremor (HP:0002080) | 4.64946554 |
| 15 | Hemiplegia (HP:0002301) | 4.59978752 |
| 16 | Abnormality of ocular smooth pursuit (HP:0000617) | 4.52534172 |
| 17 | Epileptic encephalopathy (HP:0200134) | 4.37588798 |
| 18 | Dysmetria (HP:0001310) | 4.32568471 |
| 19 | Absence seizures (HP:0002121) | 4.31786321 |
| 20 | Broad-based gait (HP:0002136) | 4.23455270 |
| 21 | Abnormality of binocular vision (HP:0011514) | 4.04054024 |
| 22 | Diplopia (HP:0000651) | 4.04054024 |
| 23 | Truncal ataxia (HP:0002078) | 3.96188962 |
| 24 | Cortical dysplasia (HP:0002539) | 3.95827644 |
| 25 | Genetic anticipation (HP:0003743) | 3.82906241 |
| 26 | Amblyopia (HP:0000646) | 3.82133309 |
| 27 | Tetraplegia (HP:0002445) | 3.81238341 |
| 28 | Hemiparesis (HP:0001269) | 3.73592924 |
| 29 | Horizontal nystagmus (HP:0000666) | 3.72887528 |
| 30 | Postural tremor (HP:0002174) | 3.67475602 |
| 31 | Dialeptic seizures (HP:0011146) | 3.67080201 |
| 32 | Polyphagia (HP:0002591) | 3.65528079 |
| 33 | Gait imbalance (HP:0002141) | 3.55593196 |
| 34 | Hypoplasia of the brainstem (HP:0002365) | 3.48965509 |
| 35 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 3.48965509 |
| 36 | Wrist flexion contracture (HP:0001239) | 3.47637317 |
| 37 | Status epilepticus (HP:0002133) | 3.39068892 |
| 38 | Exotropia (HP:0000577) | 3.36348223 |
| 39 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.34079184 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.34079184 |
| 41 | Abnormality of saccadic eye movements (HP:0000570) | 3.32690933 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 3.27426547 |
| 43 | Poor eye contact (HP:0000817) | 3.15228189 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 3.11021922 |
| 45 | Congenital primary aphakia (HP:0007707) | 3.04683871 |
| 46 | Limb ataxia (HP:0002070) | 3.02849203 |
| 47 | Ventricular fibrillation (HP:0001663) | 2.94497654 |
| 48 | Medial flaring of the eyebrow (HP:0010747) | 2.93900699 |
| 49 | Depression (HP:0000716) | 2.92249352 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.88994391 |
| 51 | Annular pancreas (HP:0001734) | 2.88075886 |
| 52 | Anxiety (HP:0000739) | 2.87897380 |
| 53 | Lissencephaly (HP:0001339) | 2.86537159 |
| 54 | Nephrogenic diabetes insipidus (HP:0009806) | 2.80266298 |
| 55 | Abnormal social behavior (HP:0012433) | 2.71671302 |
| 56 | Impaired social interactions (HP:0000735) | 2.71671302 |
| 57 | Oligodactyly (hands) (HP:0001180) | 2.67129967 |
| 58 | Agitation (HP:0000713) | 2.59764849 |
| 59 | Gait ataxia (HP:0002066) | 2.58083829 |
| 60 | Limb dystonia (HP:0002451) | 2.57063395 |
| 61 | Abnormality of the corticospinal tract (HP:0002492) | 2.55935438 |
| 62 | Intestinal atresia (HP:0011100) | 2.49782275 |
| 63 | Bundle branch block (HP:0011710) | 2.49069264 |
| 64 | Vaginal atresia (HP:0000148) | 2.48796133 |
| 65 | Myotonia (HP:0002486) | 2.46582027 |
| 66 | Lower limb asymmetry (HP:0100559) | 2.44405154 |
| 67 | Genital tract atresia (HP:0001827) | 2.43551502 |
| 68 | Pheochromocytoma (HP:0002666) | 2.41888685 |
| 69 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41104056 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.40955811 |
| 71 | Pachygyria (HP:0001302) | 2.38148136 |
| 72 | True hermaphroditism (HP:0010459) | 2.37857818 |
| 73 | Spinal canal stenosis (HP:0003416) | 2.34521881 |
| 74 | Polymicrogyria (HP:0002126) | 2.33294655 |
| 75 | Psychosis (HP:0000709) | 2.33095208 |
| 76 | Pancreatic cysts (HP:0001737) | 2.32778931 |
| 77 | Pancreatic fibrosis (HP:0100732) | 2.32735507 |
| 78 | Abnormality of the labia minora (HP:0012880) | 2.32178917 |
| 79 | Slow progression (HP:0003677) | 2.29249151 |
| 80 | Autoamputation (HP:0001218) | 2.26044500 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.23476927 |
| 82 | Confusion (HP:0001289) | 2.22567450 |
| 83 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17633705 |
| 84 | Split foot (HP:0001839) | 2.15984487 |
| 85 | Nephronophthisis (HP:0000090) | 2.14239350 |
| 86 | Spastic gait (HP:0002064) | 2.13343355 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 2.12118875 |
| 88 | Hyperventilation (HP:0002883) | 2.10288287 |
| 89 | Volvulus (HP:0002580) | 2.09882089 |
| 90 | Supranuclear gaze palsy (HP:0000605) | 2.09198282 |
| 91 | Molar tooth sign on MRI (HP:0002419) | 2.07988142 |
| 92 | Abnormality of midbrain morphology (HP:0002418) | 2.07988142 |
| 93 | Narrow nasal bridge (HP:0000446) | 2.07832831 |
| 94 | Postural instability (HP:0002172) | 2.06255005 |
| 95 | Poor coordination (HP:0002370) | 2.05502893 |
| 96 | Urinary urgency (HP:0000012) | 2.05428069 |
| 97 | Lower limb muscle weakness (HP:0007340) | 2.04402206 |
| 98 | Inability to walk (HP:0002540) | 2.01529259 |
| 99 | Incomplete penetrance (HP:0003829) | 2.01120850 |
| 100 | Stereotypic behavior (HP:0000733) | 1.99338964 |
| 101 | Hypoplasia of the corpus callosum (HP:0002079) | 1.98851522 |
| 102 | Mutism (HP:0002300) | 1.98671212 |
| 103 | Esotropia (HP:0000565) | 1.93671172 |
| 104 | Hypoplastic nipples (HP:0002557) | 1.92803890 |
| 105 | Tubulointerstitial abnormality (HP:0001969) | 1.92673797 |
| 106 | Fetal akinesia sequence (HP:0001989) | 1.91639645 |
| 107 | Tubulointerstitial nephritis (HP:0001970) | 1.91113009 |
| 108 | Pointed chin (HP:0000307) | 1.90269217 |
| 109 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88688469 |
| 110 | Neuronal loss in central nervous system (HP:0002529) | 1.86844528 |
| 111 | Sleep apnea (HP:0010535) | 1.86768186 |
| 112 | Cerebellar atrophy (HP:0001272) | 1.85895930 |
| 113 | Broad foot (HP:0001769) | 1.85572632 |
| 114 | Spastic tetraplegia (HP:0002510) | 1.85154061 |
| 115 | Postaxial hand polydactyly (HP:0001162) | 1.84887087 |
| 116 | Intellectual disability, moderate (HP:0002342) | 1.84139235 |
| 117 | Broad metatarsal (HP:0001783) | 1.81974893 |
| 118 | Focal dystonia (HP:0004373) | 1.81615803 |
| 119 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.80104861 |
| 120 | Drooling (HP:0002307) | 1.78935664 |
| 121 | Excessive salivation (HP:0003781) | 1.78935664 |
| 122 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78893581 |
| 123 | Synostosis involving the elbow (HP:0003938) | 1.78429182 |
| 124 | Humeroradial synostosis (HP:0003041) | 1.78429182 |
| 125 | Muscular hypotonia of the trunk (HP:0008936) | 1.77015829 |
| 126 | Exercise-induced myalgia (HP:0003738) | 1.75177443 |
| 127 | Epidermoid cyst (HP:0200040) | 1.75075891 |
| 128 | Abnormality of the motor neurons (HP:0002450) | 1.74745167 |
| 129 | Abnormal neuron morphology (HP:0012757) | 1.74745167 |
| 130 | Epileptiform EEG discharges (HP:0011182) | 1.74498768 |
| 131 | Nonprogressive disorder (HP:0003680) | 1.72370273 |
| 132 | Abnormality of macular pigmentation (HP:0008002) | 1.70315848 |
| 133 | Impaired vibratory sensation (HP:0002495) | 1.70185187 |
| 134 | Optic nerve hypoplasia (HP:0000609) | 1.69381741 |
| 135 | Tubulointerstitial fibrosis (HP:0005576) | 1.68969582 |
| 136 | Poor suck (HP:0002033) | 1.68954421 |
| 137 | Hypsarrhythmia (HP:0002521) | 1.65275535 |
| 138 | Dysarthria (HP:0001260) | 1.64779629 |
| 139 | Oligodactyly (HP:0012165) | 1.64540651 |
| 140 | Specific learning disability (HP:0001328) | 1.63885321 |
| 141 | Progressive inability to walk (HP:0002505) | 1.63318639 |
| 142 | Megalencephaly (HP:0001355) | 1.62956320 |
| 143 | Abnormal EKG (HP:0003115) | 1.59741801 |
| 144 | Prolonged QT interval (HP:0001657) | 1.59267260 |
| 145 | Abnormal hair whorl (HP:0010721) | 1.58407163 |
| 146 | Clonus (HP:0002169) | 1.57599251 |
| 147 | Retinal dysplasia (HP:0007973) | 1.56775251 |
| 148 | Ankle clonus (HP:0011448) | 1.56041170 |
| 149 | Absent speech (HP:0001344) | 1.55649192 |
| 150 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.55006355 |
| 151 | Bradykinesia (HP:0002067) | 1.54654588 |
| 152 | Tinnitus (HP:0000360) | 1.49135428 |
| 153 | Failure to thrive in infancy (HP:0001531) | 1.48713742 |
| 154 | Aqueductal stenosis (HP:0002410) | 1.46819328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 5.17664007 |
| 2 | EPHA3 | 4.81515615 |
| 3 | RIPK1 | 3.54263372 |
| 4 | NTRK3 | 3.31437509 |
| 5 | TRIM28 | 3.24240021 |
| 6 | WNK1 | 3.10331785 |
| 7 | MAP3K4 | 2.95296768 |
| 8 | CAMKK1 | 2.63739149 |
| 9 | CDK19 | 2.56214026 |
| 10 | DYRK2 | 2.53469307 |
| 11 | MAP2K7 | 2.52157199 |
| 12 | NTRK2 | 2.43738540 |
| 13 | MINK1 | 2.34585002 |
| 14 | MAP2K4 | 2.32057423 |
| 15 | MAP4K2 | 2.27625437 |
| 16 | MAP3K9 | 2.19894005 |
| 17 | PNCK | 2.17408712 |
| 18 | TNIK | 2.03767591 |
| 19 | STK38 | 2.02938537 |
| 20 | MARK1 | 1.97267730 |
| 21 | PAK6 | 1.90441456 |
| 22 | DYRK3 | 1.82446733 |
| 23 | PRPF4B | 1.82073884 |
| 24 | CSNK1G2 | 1.81038886 |
| 25 | PRKCG | 1.79424703 |
| 26 | PINK1 | 1.73148093 |
| 27 | CSNK1G3 | 1.71815807 |
| 28 | DYRK1B | 1.66307081 |
| 29 | EPHA4 | 1.62749900 |
| 30 | CSNK1A1L | 1.62367474 |
| 31 | WNK3 | 1.61673667 |
| 32 | OXSR1 | 1.56495442 |
| 33 | DAPK2 | 1.56173098 |
| 34 | STK16 | 1.48003782 |
| 35 | UHMK1 | 1.44707552 |
| 36 | RIPK4 | 1.43770820 |
| 37 | SGK223 | 1.41252250 |
| 38 | SGK494 | 1.41252250 |
| 39 | PTK6 | 1.39515457 |
| 40 | SGK2 | 1.37388843 |
| 41 | CSNK1G1 | 1.30316955 |
| 42 | TYRO3 | 1.27839571 |
| 43 | CAMK2G | 1.19353503 |
| 44 | CAMK1 | 1.17794498 |
| 45 | MAPK13 | 1.15940862 |
| 46 | MAP3K6 | 1.15388216 |
| 47 | CDC42BPA | 1.14981769 |
| 48 | CAMK1G | 1.11300981 |
| 49 | PRKCH | 1.09729066 |
| 50 | SGK3 | 1.08927662 |
| 51 | LIMK1 | 1.08101772 |
| 52 | ERBB3 | 1.07739129 |
| 53 | STK11 | 1.07503600 |
| 54 | CAMK4 | 1.07286965 |
| 55 | GRK5 | 1.05473349 |
| 56 | CDK5 | 1.04221167 |
| 57 | MATK | 1.02413347 |
| 58 | PLK2 | 1.01912394 |
| 59 | EPHB2 | 1.01432747 |
| 60 | ALK | 1.00389934 |
| 61 | MAPKAPK5 | 1.00314709 |
| 62 | CDK15 | 0.98928495 |
| 63 | CASK | 0.97142695 |
| 64 | CDK18 | 0.96752427 |
| 65 | CAMK2B | 0.96581071 |
| 66 | NEK6 | 0.96306977 |
| 67 | PRKG1 | 0.92462215 |
| 68 | PHKG2 | 0.88589512 |
| 69 | PHKG1 | 0.88589512 |
| 70 | CAMK2D | 0.88544684 |
| 71 | BMPR2 | 0.87210505 |
| 72 | CDK11A | 0.86588427 |
| 73 | CDK14 | 0.84447086 |
| 74 | CAMK2A | 0.81938704 |
| 75 | TESK1 | 0.80766713 |
| 76 | ROCK2 | 0.79582759 |
| 77 | SRPK1 | 0.78046723 |
| 78 | DYRK1A | 0.77928832 |
| 79 | PDK1 | 0.75780456 |
| 80 | MAP3K12 | 0.73738908 |
| 81 | OBSCN | 0.69314129 |
| 82 | ERBB2 | 0.68867691 |
| 83 | SGK1 | 0.66660613 |
| 84 | SIK2 | 0.64490208 |
| 85 | EPHB1 | 0.63630827 |
| 86 | BCR | 0.62997489 |
| 87 | HIPK2 | 0.61551256 |
| 88 | RPS6KA3 | 0.60816906 |
| 89 | CSNK1A1 | 0.56520465 |
| 90 | * PRKACA | 0.55336612 |
| 91 | FYN | 0.54873527 |
| 92 | KSR1 | 0.54081867 |
| 93 | PRKCZ | 0.53452720 |
| 94 | BRSK1 | 0.52941331 |
| 95 | KSR2 | 0.52740986 |
| 96 | AKT3 | 0.52274421 |
| 97 | ADRBK2 | 0.51751577 |
| 98 | NTRK1 | 0.50886533 |
| 99 | PDPK1 | 0.50643938 |
| 100 | RPS6KB1 | 0.49977913 |
| 101 | PRKDC | 0.49852301 |
| 102 | GRK1 | 0.49813127 |
| 103 | FER | 0.49572516 |
| 104 | SIK3 | 0.48201387 |
| 105 | FES | 0.47081250 |
| 106 | MAPK12 | 0.46851633 |
| 107 | ADRBK1 | 0.46818414 |
| 108 | PKN1 | 0.46639838 |
| 109 | PRKCA | 0.45826021 |
| 110 | CSNK1D | 0.45775104 |
| 111 | PRKACB | 0.44669026 |
| 112 | SRC | 0.44594898 |
| 113 | RET | 0.43980545 |
| 114 | RPS6KA4 | 0.43087841 |
| 115 | WNK4 | 0.43037881 |
| 116 | TNK2 | 0.42957296 |
| 117 | PRKCE | 0.42369953 |
| 118 | PTK2 | 0.41806174 |
| 119 | MAP3K2 | 0.41543208 |
| 120 | TAOK2 | 0.41523403 |
| 121 | MKNK2 | 0.40449734 |
| 122 | PRKAA1 | 0.40236545 |
| 123 | MARK2 | 0.39324750 |
| 124 | PRKACG | 0.39193735 |
| 125 | BCKDK | 0.39104166 |
| 126 | YES1 | 0.39040458 |
| 127 | INSRR | 0.38469539 |
| 128 | CSNK1E | 0.38146959 |
| 129 | PIK3CA | 0.36574235 |
| 130 | ICK | 0.36387423 |
| 131 | MAPK15 | 0.36292256 |
| 132 | BMPR1B | 0.36184399 |
| 133 | MAP3K13 | 0.35438019 |
| 134 | RPS6KA2 | 0.34984681 |
| 135 | PRKCB | 0.34588909 |
| 136 | PAK3 | 0.33614987 |
| 137 | MAPK10 | 0.33184728 |
| 138 | CDK3 | 0.32888370 |
| 139 | TESK2 | 0.30036477 |
| 140 | VRK1 | 0.29979418 |
| 141 | MAPK9 | 0.26335121 |
| 142 | PBK | 0.22406379 |
| 143 | MAPK8 | 0.21441470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.86145372 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 3.35363973 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.31874515 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 3.06047991 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 3.02792426 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.92093709 |
| 7 | * Long-term depression_Homo sapiens_hsa04730 | 2.82745235 |
| 8 | Taste transduction_Homo sapiens_hsa04742 | 2.81163003 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.79576836 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.60788533 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.31595768 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31423514 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.22670105 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.16101588 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.10803806 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.09734944 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93829016 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.91661986 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89774644 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.88670417 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81291899 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.76509376 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.76068370 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.72840372 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.71073214 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.70769126 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.69220981 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58907800 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56550332 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56423545 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54152485 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42524114 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41898507 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41360514 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.40832493 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40596564 |
| 37 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.25599177 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.23324226 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.18307109 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18080447 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16386136 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14187893 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.11497432 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03457762 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02445606 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01804215 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96444037 |
| 48 | Protein export_Homo sapiens_hsa03060 | 0.96018053 |
| 49 | Cocaine addiction_Homo sapiens_hsa05030 | 0.95981977 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95338158 |
| 51 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93586819 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92814539 |
| 53 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89122633 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88466184 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86739421 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85548734 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85525516 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84567134 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84210150 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83976335 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83680692 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82788514 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80757269 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.80753263 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80356237 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78707038 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78139490 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.73361472 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72072088 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65835560 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65655799 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64513491 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63370801 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60105975 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58954289 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58749651 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55743897 |
| 78 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54002127 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52852930 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51909925 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51588851 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.51476296 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51262423 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50889044 |
| 85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50118043 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49382477 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48989655 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48367015 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.47061265 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46710735 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.45704708 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45340271 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41169598 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.41135042 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39903178 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39727180 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39715527 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.39634592 |
| 99 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39040724 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38635733 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38193723 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.37892834 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37501247 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37207159 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37174819 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36571914 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34471594 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34316708 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34083444 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33170670 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32575272 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31821681 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31547886 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29849098 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29696570 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29507839 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.29099270 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29047209 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.28959473 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.28576888 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27789639 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27761861 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27299599 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27043966 |
| 125 | RNA degradation_Homo sapiens_hsa03018 | 0.25924576 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25289922 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23788393 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23625233 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.23348995 |
| 130 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.22762248 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21488329 |
| 132 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.21120161 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.19088221 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18262249 |
| 135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17341042 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16208733 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.15644265 |

